Interleukin 12 (IL-12) has a keg role during the initial phase of the immune response, favouring development of T helper class 1 (Th1) cells. IL-12 is composed of two subunits, p35 and p40, which are both needed for bioactivity. The level of p35 expression determines the level of bioactive IL-12 (p70), while the p40 subunit is produced in excess, In the present study we examined the sensitivity of bioactive IL-12 production by human monocytes to a corticosteroid, budesonide, We also compared the corticosteroid sensitivity of IL-12 and two other cytokines, interleukin 1 beta and granulocyte-macrophage colony-stimulating factor (GM-CSF). Monocytes obtained from peripheral blood of healthy donors (n = 12) were stimulated with lipopolysaccharide (LS; 10 mu g/ml; 20 h) in the presence or absence of budesonide (10(-11)-10(-7) M). The supernatants were assayed for IL-12 (p70). IL-1 beta and GM-CSF concentrations using specific immunoassays. Budesonide potently inhibited the production of bioactive IL-12, A significant suppression was obtained by treatment with even very low budesonide concentrations; even 10(-11) M budesonide significantly inhibited IL-12 to 81.6 +/- 7.6% of the control level (P < 0.05). The maximal inhibitory effect of budesonide was seen at 10(-8) M. The inhibition of IL-12 production was significantly higher than the inhibition of GM-CSF (P < 0.01) or IL-1 beta (P < 0.001), Whereas IL-12 production was totally inhibited, GM-CSF production,vas inhibited to 16.4 +/- 3.7 and IL-1 beta production to 43.1 +/- 7.3% of control, respectively, The dramatic capacity of corticosteroids to modulate production of IL-12 as well as other cytokines may be a major mechanism underlying the effectiveness of these drugs in a broad spectrum of inflammatory, diseases. (C) 1998 Academic Press.